Abstract
Prosthetic valve replacement is the mainstay of treatment for patients with severe symptomatic valvular heart disease but in the process, the native valvular disease is exchanged with prosthesisrelated complications.
Highlights
Prosthetic valve thrombosis (PVT) is a rare but serious complication of valve replacement, most often encountered with mechanical prostheses
The most important risk factor attributed to the occurrence of prosthetic valve thrombosis was non-compliance to treatment leading to subtherapeutic INR
Mitral valve thrombosis was most commonly seen and Fibrinolysis can be considered as effective therapy even in patients presenting with NYHA Class III/IV especially in resource-stricken developing countries
Summary
Prosthetic valve thrombosis (PVT) is a rare but serious complication of valve replacement, most often encountered with mechanical prostheses. The present study aims to evaluate patients with prosthetic valve thrombosis in terms of the clinical characteristics, risk determinants, treatment, and outcomes in the prospective observational study. Prosthetic valve replacement is the mainstay of treatment for patients with severe symptomatic valvular heart disease but in the process, the native valvular disease is exchanged with prosthesisrelated complications. The incidence of obstructive PVT for mechanical valves varies between 0.3-1.3-3% patient years[2,3]. The incidence ranges from 0.1% to almost 6% per patient-year for left-sided valves and up to 20% for tricuspid valves[4]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.